Interferon, its clinical significance and use
Bektemirov, T.A.; Shul'tsev, G.P.
Terapevticheskii Arkhiv 45(1): 10-15
1973
ISSN/ISBN: 0040-3660 PMID: 4588909 Document Number: 69012
Document emailed within 1 workday
Related Documents
Rudick, R.A. 2003: Biologic impact of interferon antibodies, and complexities in assessing their clinical significance Neurology 61(9 Suppl 5): S31-S34Borecký, L. 1976: Interferon 1976. II. the significance of interferon in medicine Bratislavske Lekarske Listy 66(6): 645-652
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Kasparov, A.A. 1972: The significance of interferon inductors in current antiviral therapy for herpetic eye disease Vestnik Oftalmologii 2: 63-67
Gerken, G. 1993: What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data? Der Internist 34(11): 1062-1065
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Maisch, B.; Schuff-Werner, P.; Berg, P.A.; Kochsiek, K. 1979: Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. the significance of serum inhibition and rosette inhibitory factors Clinical and Experimental Immunology 38(2): 198-203
Aleshkin, V.A.; Astakhin, A.V.; Afanas'ev, S.S.; Levitan, B.N.; Chishieva, E.M.; Afanas'ev, D.S.; Denisov, L.A.; Afanas'ev, M.S. 2002: Diagnostic and prognostic significance of characteristics of serum interferon antiviral activity in chronic and acute diffuse liver diseases Klinicheskaia Laboratornaia Diagnostika 8: 48-50
Ishida, Y.; Kawada, T.; Sugino, N. 1983: Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 56: 160-167
Brosjö, O.; Bauer, H.C.; Broström, L.A.; Nilsson, O.S.; Reinholt, F.P.; Tribukait, B. 1987: Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation Cancer Research 47(1): 258-262
Sinkovics, J.G. 1991: Clinical use of interferon Orvosi Hetilap 132(37): 2065
Jakó, J. 1991: Clinical use of interferon Orvosi Hetilap 132(36): 2010
Zamorska, I.; Kozłowski, M. 1990: Interferon--clinical application Wiadomosci Lekarskie 43(11): 548-551
Nosik, N.N.; Ershov, F.I. 1980: Clinical use of interferon and its inducers Antibiotiki 25(9): 695-710
Shishido, A.; Kohno, S. 1977: Problems of clinical application of interferon Nihon Rinsho. Japanese Journal of Clinical Medicine 35(9): 2832-2837
Imanishi, J.; Kishida, T. 1981: Clinical trials with interferon in Japan Texas Reports on Biology and Medicine 41: 647-652
Flury, F.; Wegmann, T. 1979: Clinical experiences with the interferon therapy Schweizerische Rundschau für Medizin Praxis 68(43): 1401-1405
Bazarnyĭ, V.V.; Danilov, E.P.; Kovaleva, A.V.; Tsvirenko, S.V. 2004: The clinical and diagnostic significance of laboratory examinations in prognosticating the clinical course of craniocerebral trauma Klinicheskaia Laboratornaia Diagnostika 8: 25
Petricciani, J.; Esber, E.; Attallah, A.; Hopps, H. 1981: Safety considerations for interferon used in clinical research Texas Reports on Biology and Medicine 41: 289-293